Gene ID’d as potential therapeutic target for dementia in Parkinson’s

Gene ID’d as potential therapeutic target for dementia in Parkinson’s
Dementia is one of the most debilitating consequences of Parkinson's disease, a progressive neurological condition characterized by tremors, stiffness, slow movement and impaired balance. Eighty percent of people with Parkinson's develop dementia within 20 years of the diagnosis, and patients who carry a particular variant of the gene APOE are at especially high risk. ... read more
Source: Medical XpressPublished on 2020-02-05